Noteworthy is the link between SOX2 overexpression and tamoxifen resistance in MCF7 breast cancer cells, where MLN4924 treatment was demonstrated to induce MSX2 accumulation through FBXW2 inhibition, ultimately suppressing SOX2 expression.89 Here, SOX2 is linked to breast carcinoma.